- 1 FDA: Coronavirus (COVID-19) Update: Daily Roundup
- 2 MESA BIOTECH: Receives Emergency Use Authorization from FDA for a 30 Minute Point of Care Molecular COVID-19 Test
- 3 BIOHAVEN: To Advance Vazegepant into Phase 3 for the Acute Treatment of Migraine Following Successful End of Phase 2 Meeting with FDA
- 4 NEXVOO: The NEXVOO® factory operates as a Healthcare Certified Factory in Xiamen, China with a direct sourcing partnership to ship FDA Certified N95 Masks
- 5 MCRA: Launches Medical Device U.S. FDA Regulatory & Clinical Trial Advisory Support & Call Center to Assist with the COVID-19 Pandemic
Get the latest business news and updates - delivered right to your inbox
By signing up you agree to receive email newsletters or alerts from FDA Reporter. You can unsubscribe at any time.